Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q1 2017 Earnings

15MayExpected
Q2 2016
Q3 2016
Q4 2016
Q1 2017
-4,905
-3,270.33
-1,635.66
-0.99

Details

Expected EPS
-0.99
Actual EPS
-27.4
Surprise EPS
-26.41
Surprise Percent
+2,667.68%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -27.4 per share for Q1 2017.

0 Comments

Share your thoughts